Chemed ROI - Return on Investment 2010-2025 | CHE

Chemed return on investment for the quarter ending March 31, 2025 was 121.43.

  • Chemed average return on investment for 2024 was 121.43, a 103.33% decline from 2023.
  • Chemed average return on investment for 2023 was 59.72, a 35.39% increase from 2022.
  • Chemed average return on investment for 2022 was 44.11, a 70% increase from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Chemed ROI - Return on Investment 2010-2025 | CHE

  • Chemed average return on investment for 2024 was 121.43, a 103.33% decline from 2023.
  • Chemed average return on investment for 2023 was 59.72, a 35.39% increase from 2022.
  • Chemed average return on investment for 2022 was 44.11, a 70% increase from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$18.3B
DaVita (DVA)$11.2B
Encompass Health (EHC)$10.4B
Option Care Health (OPCH)$5.3B
Elanco Animal Health (ELAN)$4.2B
RadNet (RDNT)$3.7B
Amedisys (AMED)$3B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$1.8B
Astrana Health (ASTH)$1.6B
U.S Physical Therapy (USPH)$1B
Pennant (PNTG)$907M
Aveanna Healthcare Holdings (AVAH)$886M
Atai Life Sciences (ATAI)$294M
Daxor (DXR)$36M
Ontrak (OTRK)$6M
MEDIROM Healthcare Technologies (MRM)$4M
Psychemedics (PMD)$0M